In 2007, Novo Nordisk and Chinese Academy of Sciences (CAS) established the Novo Nordisk - Chinese Academy of Sciences Research Fund.
The Fund supports projects of interest to both CAS and Novo Nordisk in the fields of diabetes, biopharmaceuticals and protein sciences that are jointly submitted by scientists from CAS and Novo Nordisk. The projects include research projects, workshops, PhD fellowships and PostDoc fellowships, and exchange visits. The Fund has also supported CAS-NN Great Wall Professorships in Protein Sciences to build relations to rising stars at CAS.
In total, Novo Nordisk has donated 4.8 million USD to the Fund. On average, the Fund has annually supported 8 projects and in total 8 Great Wall Professorships.
The fund currently supports the following programs:
• Research Projects
The deadline for applications is 31 October 2015, see latest Call for Research Projects Proposals.
• Collaboration Consortia
Applications for a Collaboration Consortium may be submitted any time as from 1 February 2015, see latest Call for Collaboration Consortia Proposals.
• Young Scientist Grant
The deadline for applications is 31 October 2015, see latest Call for Young Scientist GrantProposals.
There is an open Call for Workshops.
The Fund welcomes joint applications that include partners from Danish or Swedish Universities that normally will pay for their own participation. The Fund also supports projects, fellowships or workshops of relevance to the Sino-Danish Centre for Education and Researchwww.sinodanishcenter.dk.
Governance of the Fund is composed of a Steering Committee and a Board
The Steering Committee has the overall responsibility for the Fund, comprising one member from CAS and one from Novo Nordisk:
Prof. ZHANG Yaping, Vice President of CAS (chair)
Prof. Peter Kurtzhals, Senior Vice President and Head of Global Research, Novo Nordisk (vice-chair)
The Board has 4 members from CAS and 4 from Novo Nordisk:
Prof. XU Ruiming, Director-General, Bureau of Frontier Sciences and Education (chair)
Prof. CAO Jinghua, Deputy Director-General, the Bureau of International Cooperation
Prof. XU Tao, Director-General, Institute of Biophysics
Prof. WANG Ming-Wei, Director, National Center for Drug Screening, Shanghai Institute of Materia Medica
Novo Nordisk members:
Prof. Boerge Diderichsen, Vice President & Head of R&D Outreach (vice-chair)
Dr. Soeren Tullin, Corporate Vice President, Discovery Biology and Technology, R&D
Dr. WANG Baoping, President & Head of Novo Nordisk Research Center China
Dr. ZHANG Fang, Vice President, Discovery Biology China
For more info on Novo Nordisk, visit: www.novonordisk.com
For more info contact:
Ms. WANG Dongyao, Secretary of the Board,
Program Officer, Bureau of International Cooperation, CAS
Dr. Boerge Diderichsen, Vice President & Head of R&D Outreach, Novo Nordisk